Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
96.34% 106.98% 132.25% 122.67%

+8 more TTM periods

Piotroski F-Score
7 6 6 6
ROA
3.33% 3.33% 2.20% 2.16%
ROIC
15.65% 12.64% 20.29% 32.52%
Return on Tangible Assets
(256.39%) (1,370.54%) (64.24%) (51.08%)
Average Days of Receivables
27.91 27.64 29.11 28.65
Free Cash Flow per Share
21.26 8.23 18.79 16.55
Free Cash Flow
4,105.92 1,601.89 3,650.33 3,207.14
Capital Expenditures
(715.03) (674.25) (638.41) (667.98)
Other line items
Cash ROIC
23.10% 8.83% 31.01% 23.30%
Accounts Receivable Turnover
13.31 13.52 12.90 13.09
Accounts Payable Turnover
6.04 6.20 5.92 5.87
Inventory Turnover
15.52 16.22 14.08 15.69
Average Days of Payables
62.48 59.90 65.21 64.46
Days of Inventory on Hand
24.02 23.10 28.01 24.14
Tax Rate
(0.27) (0.27) (0.30) (0.31)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.30% 2.19% 2.09% 2.02%
Share Based Compensation of Revenue
0.04% 0.04% 0.04% 0.05%
Interest Coverage
7.05 7.49 7.98 9.02
Operating CF/Net income
1.84 0.89 2.64 2.49
Depreciation/Fixed assets
0.38 0.37 0.43 0.42
Capex/Depreciation
(0.67) (0.64) (0.61) (0.63)
Revenue per Share
1,722.89 1,689.48 1,677.37 1,657.89
Operating CF per Share
24.96 11.70 22.08 19.99
Capex per Share
(3.70) (3.47) (3.29) (3.45)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates